Covered recipient · General Payments record
SINDU STEPHEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,958.78
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.62 | 14 |
| Education | $20.87 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $109.08 | 3 |
| ABBVIE INC. | $85.57 | 5 |
| Janssen Biotech, Inc. | $31.64 | 1 |
| GENZYME CORPORATION | $22.41 | 1 |
| Celltrion USA Inc. | $20.87 | 1 |
| Gilead Sciences, Inc. | $19.01 | 1 |
| CapsoVision, Inc. | $17.49 | 1 |
| Ardelyx, Inc. | $15.93 | 1 |
| PFIZER INC. | $14.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.14 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161103 | CMS |
| ABBVIE INC. | $16.13 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161105 | CMS |
| ABBVIE INC. | $18.94 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161107 | CMS |
| ABBVIE INC. | $16.15 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161109 | CMS |
| ABBVIE INC. | $18.21 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161111 | CMS |
| Ardelyx, Inc. | $15.93 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146709581 | CMS |
| CapsoVision, Inc. | $17.49 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154307988 | CMS |
| Celltrion USA Inc. | $20.87 | 04/08/2024 | Education | Undisputed | 01/23/2026 | 1075858679 | CMS |
| GENZYME CORPORATION | $22.41 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139729036 | CMS |
| Gilead Sciences, Inc. | $19.01 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133757524 | CMS |
| Janssen Biotech, Inc. | $31.64 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078788946 | CMS |
| PFIZER INC. | $14.49 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131179383 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.30 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137682129 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.57 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137682131 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.21 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137682133 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.